| 摘要 |
The present invention is directed to compositions comprising a nanopartic ulate modafinil compositions, or a salt(s), or an enantiomer(s), or a prodru g(s), or a polymorph(s) or derivative thereof, having improved bioavailabili ty. The nanoparticulate modafinil composition formulation particles of the c omposition have an effective average particle size of less than about 2000 n m and are useful in the treatment of dyssomnias, including but not limited t o, narcolepsy, chronic fatigue, eating disorders, compulsive behaviors, ADHD , addictions, substance abuse, sleepiness, nervous system diseases, conditio ns, syndromes, and symptoms and related diseases, conditions, and symptoms.< /SDOAB>
|
